Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Tech Coloproctol ; 25(5): 569-577, 2021 05.
Artículo en Inglés | MEDLINE | ID: mdl-33792823

RESUMEN

BACKGROUND: The aim of our study was to investigate the correlation among T2-weighted (T2w) images, apparent diffusion coefficient (ADC) maps, 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) images, histogram analysis and the pathological response in locally advanced rectal cancer (LARC) after preoperative chemoradiotherapy (pCRT). METHODS: Patients with LARC were prospectively enrolled between February 2015 and August 2018 and underwent PET/magnetic resonance imaging (MRI). MRI included T2w and diffusion-weighted imaging (DWI)-sequences. ADC maps and PET images were matched to the T2w images. Voxel-based standardized uptake values (SUVs,) ADC and T2w-signal-intensity values were collected from the volumes of interest (VOIs) and mean, skewness and kurtosis were calculated. Spearman's correlation coefficient was applied to evaluate the correlation among the variables and tumor regression grade (TRG), T stage, N stage and fibrosis. RESULTS: Twenty-two patients with biopsy-proven LARC in the low or mid rectum were enrolled [17 males, mean age was 69 years (range 49-85 years)]. Seven patients experienced complete regression (TRG1). A significant positive correlation was found between SUV mean values (ρ = 0.480; p = 0.037) and TRG. No other significant correlations were found. CONCLUSIONS: Histogram analysis of SUV values is a predictor of TRG in LARC.


Asunto(s)
Fluorodesoxiglucosa F18 , Neoplasias del Recto , Anciano , Anciano de 80 o más Años , Quimioradioterapia , Imagen de Difusión por Resonancia Magnética , Humanos , Masculino , Persona de Mediana Edad , Terapia Neoadyuvante , Tomografía de Emisión de Positrones , Neoplasias del Recto/tratamiento farmacológico , Neoplasias del Recto/terapia
2.
J Visc Surg ; 159(6): 471-479, 2022 12.
Artículo en Inglés | MEDLINE | ID: mdl-34794901

RESUMEN

AIM OF THE STUDY: Nomograms have been proposed to assess prognosis following curative surgery for gastric cancer. The objective of the current study was to evaluate the performance of the Gastric Cancer Collaborative Group nomograms developed in 2014 by Kim et al., using a cohort of patients from a 10-year single institution experience in gastric cancer management. PATIENTS AND METHODS: We retrospectively reviewed patients who underwent curative-intent surgery for histologically confirmed gastric cancer at First Surgical Clinic of Padua University Hospital (Italy) from January 2010 to May 2020. Univariable and multivariable Cox proportional hazard models were employed to assess the effect of the variables of interest on mortality and recurrence. Multivariable analysis was performed by considering the variables included in the Gastric Cancer Collaborative Group nomograms in order to validate them. The performance of the nomograms was evaluated using Harrell's C-index and calibration plots. RESULTS: Overall, 168 patients were included, with a median follow-up of 20.1 months. On multivariable analysis, tumor location, lymph node ratio, and pathological T stage were associated with recurrence; age, tumor location, lymph node ratio, and pT stage were associated with OS (overall survival). The nomograms had good discriminatory capability to classify both OS (C-index: 0.75) and DFS (disease-free survival) (C-index 0.72). The corrected C-Index for DFS based on the AJCC staging system revealed better prediction (C-Index 0.75), while the corrected C-Index for OS had worse discrimination ability compared with the current nomogram (C-Index 0.72). CONCLUSIONS: The Gastric Cancer Collaborative Group nomograms demonstrated good performances in terms of prediction of both OS and DFS on external validation. The two nomograms are easy to apply, and variables included are widely available to most facilities.


Asunto(s)
Nomogramas , Neoplasias Gástricas , Humanos , Neoplasias Gástricas/patología , Estudios Retrospectivos , Pronóstico , Estadificación de Neoplasias
3.
Scand J Surg ; 109(1): 18-28, 2020 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-31960765

RESUMEN

BACKGROUND AND AIMS: It has become clear that vein resection and reconstruction for pancreatic ductal adenocarcinoma (PDAC) is the standard of care as supported by multiple guidelines. However, resection of large peri-pancreatic arteries remains debatable. MATERIALS AND METHODS: This review examines the current state of vascular resection with curative intent for PDAC in the last 5 years. Herein, we consider venous (superior mesenteric vein, portal vein), as well as arterial (superior mesenteric artery, celiac trunk, hepatic artery) resection or both with or without reconstruction. RESULTS: Improvement of multidrug chemotherapy has revolutionized care for PDAC that should shift traditional surgical thinking from an anatomical classification of resectability to a prognostic and biological classification. CONCLUSION: The present review gives an overview on the results of pancreatectomy associated with vascular resection, with consideration of new perspectives offered by the availability of better systemic therapies.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Carcinoma Ductal Pancreático/cirugía , Pancreatectomía/mortalidad , Neoplasias Pancreáticas/cirugía , Neoplasias Vasculares/cirugía , Procedimientos Quirúrgicos Vasculares/métodos , Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Carcinoma Ductal Pancreático/mortalidad , Carcinoma Ductal Pancreático/patología , Arteria Celíaca/patología , Arteria Celíaca/cirugía , Arteria Hepática/patología , Arteria Hepática/cirugía , Humanos , Arteria Mesentérica Superior/patología , Arteria Mesentérica Superior/cirugía , Terapia Neoadyuvante , Invasividad Neoplásica , Estadificación de Neoplasias , Páncreas/cirugía , Pancreatectomía/métodos , Neoplasias Pancreáticas/mortalidad , Neoplasias Pancreáticas/patología , Sistema Porta/patología , Sistema Porta/cirugía , Pronóstico , Neoplasias Vasculares/mortalidad , Neoplasias Vasculares/patología , Procedimientos Quirúrgicos Vasculares/mortalidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA